SIMULTANEOUS DETERMINATION OF MESALAZINE AND RIFAXIMIN IN SYNTHETIC MIXTURE USING SPECTROPHOTOMETRIC TECHNIQUE (SIMULTANEOUS EQUATION METHOD)

Krishna V. Prajapati, H. Raj, V. Jain, Neelam S. Prajapati
{"title":"SIMULTANEOUS DETERMINATION OF MESALAZINE AND RIFAXIMIN IN SYNTHETIC MIXTURE USING SPECTROPHOTOMETRIC TECHNIQUE (SIMULTANEOUS EQUATION METHOD)","authors":"Krishna V. Prajapati, H. Raj, V. Jain, Neelam S. Prajapati","doi":"10.5281/ZENODO.51062","DOIUrl":null,"url":null,"abstract":"Objective: A simple, accurate and precise spectroscopic method was developed for simultaneous estimation of Mesalazine and Rifaximin in synthetic mixture using Simultaneous Equation Method. Objective of the study was to deliver information related to Mesalazine and Rifaximin combination’s analytical method. Methods: The absorbance was measured at 328 nm for Mesalazine and 292 nm for Rifaximin and calibration curves were plotted as absorbance versus concentration, respectively. The method was found to be linear (r 2 > 0.999) in the range of 10-50 μg/ml for Mesalazine at 328 nm. The linear correlation was obtained (r 2 > 0.999) in the range of 10-50 μg/ml for Rifaximin at 292 nm. Results: The limit of determination (LOD) was 0.215 μg/ml and 0.214μg/ml for Mesalazine and Rifaximin respectively. The limit of quantification (LOQ) was 0.652 μg/ml and 0.648 μg/ml for Mesalazine and Rifaximin respectively. The accuracy of this method was evaluated by recovery studies and good recovery results were obtained greater than 99%. The method was successfully applied for simultaneous determination of Mesalazine and Rifaximin in binary mixture. Conclusions: The method was successfully applied to pharmaceutical synthetic mixture which is considered in approved patent which show no interference. The result of analysis has been validated statistically and by recovery studies. So this method accurate, precise, robust, rugged and economic in nature.","PeriodicalId":19998,"journal":{"name":"Pharmaceutical and Biological Evaluations","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical and Biological Evaluations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/ZENODO.51062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6

Abstract

Objective: A simple, accurate and precise spectroscopic method was developed for simultaneous estimation of Mesalazine and Rifaximin in synthetic mixture using Simultaneous Equation Method. Objective of the study was to deliver information related to Mesalazine and Rifaximin combination’s analytical method. Methods: The absorbance was measured at 328 nm for Mesalazine and 292 nm for Rifaximin and calibration curves were plotted as absorbance versus concentration, respectively. The method was found to be linear (r 2 > 0.999) in the range of 10-50 μg/ml for Mesalazine at 328 nm. The linear correlation was obtained (r 2 > 0.999) in the range of 10-50 μg/ml for Rifaximin at 292 nm. Results: The limit of determination (LOD) was 0.215 μg/ml and 0.214μg/ml for Mesalazine and Rifaximin respectively. The limit of quantification (LOQ) was 0.652 μg/ml and 0.648 μg/ml for Mesalazine and Rifaximin respectively. The accuracy of this method was evaluated by recovery studies and good recovery results were obtained greater than 99%. The method was successfully applied for simultaneous determination of Mesalazine and Rifaximin in binary mixture. Conclusions: The method was successfully applied to pharmaceutical synthetic mixture which is considered in approved patent which show no interference. The result of analysis has been validated statistically and by recovery studies. So this method accurate, precise, robust, rugged and economic in nature.
分光光度法同时测定合成混合物中美沙拉嗪和利福昔明(联立方程法)
目的:建立一种简便、准确、精密度高的联用方程法同时测定合成混合物中美沙拉嗪和利福昔明含量的方法。本研究旨在为美沙拉嗪与利福昔明联合用药的分析方法提供相关信息。方法:在328 nm处测定美沙拉嗪和292 nm处测定利福昔明的吸光度,并绘制吸光度-浓度曲线。在328 nm范围内,美萨拉嗪的检测浓度在10 ~ 50 μg/ml范围内呈线性(r 2 > 0.999)。利福昔明在292 nm范围内10 ~ 50 μg/ml呈线性相关(r 2 > 0.999)。结果:美沙拉嗪和利福昔明的检出限(LOD)分别为0.215和0.214μg/ml。美沙拉嗪和利福昔明的定量限分别为0.652 μg/ml和0.648 μg/ml。通过回收率研究对该方法的准确度进行了评价,回收率大于99%。该方法可用于同时测定美沙拉嗪和利福昔明的含量。结论:该方法成功地应用于已批准专利的药物合成混合物中,无干扰。分析结果已通过统计和恢复研究得到验证。因此这种方法准确、精密、坚固、坚固、经济。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信